Thomas W. Dubensky's Net Worth
$7.28 Million
Who is Thomas W. Dubensky?
Thomas W. Dubensky has an estimated net worth of $7.28 Million. This is based on reported shares across multiple companies, which include ADURO BIOTECH, INC., Tempest Therapeutics, Inc., and HTG MOLECULAR DIAGNOSTICS, INC.
SEC CIK
Thomas W. Dubensky's CIK is 0001635590
Past Insider Trading and Trends
2016 was Thomas W. Dubensky's most active year for acquiring shares with 18 total transactions. Thomas W. Dubensky's most active month to acquire stocks was the month of May. 2017 was Thomas W. Dubensky's most active year for disposing of shares, totalling 26 transactions. Thomas W. Dubensky's most active month to dispose stocks was the month of November. 2016 saw Thomas W. Dubensky paying a total of $234,922.35 for 264,800 shares, this is the most they've acquired in one year. In 2017 Thomas W. Dubensky cashed out on 600,000 shares for a total of $3,193,213.18, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ADURO BIOTECH, INC. No price found
Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$6.19 | -$519,203.48 | 39.9K |
Scheduled
|
Aug 10 - Aug 11
| ||
Form 4
|
—
|
0
|
$5.93 | -$540,637.58 | 39.9K |
Scheduled
|
Jul 3 - Jul 6
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
$5.28 | -$1,372,740.47 | 39.9K |
Scheduled
|
Jun 1 - Jun 5
| ||
Form 4
|
—
|
0
|
$5.22 | -$53,564.15 | 39.9K |
Scheduled
|
May 11 - May 12
| ||
Form 4
|
—
|
0
|
$5.87 | -$254,631.67 | 39.9K |
Scheduled
|
Mar 9
| ||
Form 4
|
—
|
0
|
$5.84 | -$265,990.00 | 39.9K |
Scheduled
|
Jan 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 4
|
—
|
0
|
$5.99 | -$247,607.41 | 39.9K |
Scheduled
|
Dec 1
| ||
Form 4
|
—
|
0
|
$8.04 | -$336,819.84 | 39.9K |
Scheduled
|
Nov 10
| ||
Form 4
|
—
|
0
|
$6.89 | -$289,470.18 | 39.9K |
Scheduled
|
Oct 3
| ||
Form 4
|
∞
| 39.9K |
—
|
—
| 39.9K |
Sep 12
| |||
Form 4
|
—
|
0
|
$7.58 | -$322,516.49 |
0
|
Scheduled
|
Sep 1
| ||
Form 4
|
—
|
0
|
$8.08 | -$354,875.00 |
0
|
Scheduled
|
Aug 11
| ||
Form 4
|
—
|
0
|
$6.32 | -$264,286.73 |
0
|
Scheduled
|
Jul 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
| -100.00% | -905.00 |
$8.20 | -$7,421.00 |
0
|
Scheduled
|
May 16
| ||
Form 4
|
—
|
0
|
$15.53 | -$325,372.77 |
0
|
Scheduled
|
Jan 4
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 4
|
—
|
0
|
$15.71 | -$813,731.48 |
0
|
Scheduled
|
Dec 1
| ||
Form 4
| -100.00% | -1.47K |
$14.86 | -$846,055.80 |
0
|
Scheduled
|
Nov 16 - Nov 17
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tempest Therapeutics, Inc. (TPST) Snapshot price: $4.17
President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
| +1.80% | 2K |
$4.78 | $9,560.00 | 113.34K |
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
∞
| 111.34K |
—
|
—
| 111.34K |
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HTG MOLECULAR DIAGNOSTICS, INC (HTGMQ) Snapshot price: $0.0013
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||